http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1248620-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-04
filingDate 2000-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08af740406120c987008fbbd7da03f99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bf8d3ea1c74f1a5570c76904fe72b22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b54d1ba3a1bf622ce478a0fc3809d4d3
publicationDate 2002-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1248620-A1
titleOfInvention A new use of levosimendan
abstract Levosimendan, or (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile, which has been previously suggested for the treatment of congestive heart failure is useful in the treatment of sick sinus syndrome and/or sinoatrial conduction disorders.
priorityDate 1999-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4197
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10989605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128991528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226461901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70079733
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57089479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226459474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129232388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233023700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135922523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846

Total number of triples: 37.